Prelude Therapeutics (PRLD) Return on Assets [ROA] (2020 - 2026)
Prelude Therapeutics (PRLD) reported Return on Assets [ROA] of -43.62% for Q2 2026, up 61.78 percentage points from -105.40% a year earlier and up 20.86 percentage points from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2025, Prelude Therapeutics posted Return on Assets [ROA] of -66.01%, down 4.35 percentage points from FY2024.
- Return on Assets [ROA] has declined for four consecutive years, with a five-year change of -18.13 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -61.66% in FY2024 (-8.55 pp), -53.11% in FY2023 (-6.10 pp), -47.01% in FY2022 (-3.98 pp) and -43.03% in FY2021 (+4.85 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q1 2022.
- Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -12.81 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 61.78 percentage points); the low point was Q3 2025 (a drop of 47.49 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -64.48% (Q1 2026), -88.59% (Q4 2025) and -115.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Prelude Therapeutics | 292.88 Mn | -304.42 Mn | - | -43.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.62% |
| Mar 31, 2026 | -64.48% |
| Dec 31, 2025 | -88.59% |
| Sep 30, 2025 | -115.46% |
| Jun 30, 2025 | -105.40% |
| Mar 31, 2025 | -88.38% |
| Dec 31, 2024 | -74.97% |
| Sep 30, 2024 | -67.98% |
| Jun 30, 2024 | -60.36% |
| Mar 31, 2024 | -52.41% |
| Dec 31, 2023 | -49.34% |
| Sep 30, 2023 | -47.59% |
| Jun 30, 2023 | -52.33% |
| Mar 31, 2023 | -58.43% |
| Dec 31, 2022 | -53.38% |
| Sep 30, 2022 | -49.13% |
| Jun 30, 2022 | -45.80% |
| Mar 31, 2022 | -41.67% |
| Dec 31, 2021 | -35.75% |
| Sep 30, 2021 | -29.43% |
API Access
Prelude Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();